Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by stockbuphoonon Jun 15, 2021 10:27am
82 Views
Post# 33387858

Another big plunge today on Kedrion

Another big plunge today on Kedrion Last opportunity to buy before paying $3M a month. Interesting that it is taking so long for Kedrion to think about it. Are they weighing the odds of carrying this division versus the ramp up time of getting insurance companies to fund Ryplazim? Only positive is that Liminal would get 100% of voucher if Kedrion decides not to buy plasma ppps division. Then, they could provide someone the division for free to produce it. Maybe some startup in Canada with some financial acumen could produce and sell Ryplazim. Maybe Pierre Laurin will buy it through his distribution company? Who knows but it will be mysterious and under the table.
<< Previous
Bullboard Posts
Next >>